[ad_1]
TUESDAY, Oct. 27, 2020 — Factors such as sex, age and severity of the disease may help identify COVID-19 survivors who have high levels of antibodies that can protect against the disease, a new study suggests.
“These were significant patient characteristics that not only predicted the amount of antibody but the quality of that antibody,” said lead author Sabra Klein, a professor in the Department of Molecular Microbiology and Immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore.
Specifically, older men who have recovered after a hospital stay for COVID-19 may be good candidates for donating plasma for treating other infected patients, the study suggests.
Plasma trials are continuing, but doctors are unsure how to select COVID-19 survivors who are most likely to have strong antibody responses.
For the study, researchers tested the blood of 126 COVID-19 survivors and found many differences in their antibody levels and their antibodies’ ability to neutralize SARS-CoV-2. Factors linked with stronger antibody responses included being sick enough to be hospitalized, being older and being male.
“We know that the magnitude of antibody responses correlates with disease severity in other infectious diseases, such as active tuberculosis,” Klein said in a Hopkins news release.
The findings were recently published in the Journal of Clinical Investigation.

© 2020 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
More News Resources
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022